Women who suffer the misery of migraines at the time of their period could be helped by a new treatment, according to a study, quoted by BBC. The headaches can be prevented by taking a new drug before menstruation, a US trial suggests.

The therapy, frovatriptan succinate, is already available in the US.

Frovatriptan is a member of a class of drugs called triptans, which reduce inflammation of certain blood vessels in the brain thought to cause pain.

It is currently prescribed for acute migraine attacks but its use could be extended as a prevention for menstrually associated migraines (MAM).

We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!